Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Linde

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|June 11, 2021
Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-PatientsJohannes Rosenbrock, Andrés Vásquez-Torres, Horst Mueller, et al.
Radiation Oncology (London, England)|January 3, 2025
Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes-a single centre analysisJulia Katharina Schleifenbaum, Janis Morgenthaler, Shachi Jenny Sharma, et al.
Cancers|September 2, 2020
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score MatchingMaike Trommer, Jaika Kinsky, Anne Adams, et al.
Molecular Imaging and Biology|June 30, 2022
Head-to-Head Comparison of [<sup>68</sup> Ga]Ga-FAPI-46-PET/CT and [<sup>18</sup>F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck CancerSimone Wegen, Lutz van Heek, Philipp Linde, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 13, 2021
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approachPhilipp Linde, Christian Baues, Simone Wegen, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study GroupJohannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 27, 2023
Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)Marcel Büttner, Philip Melton, Rainer Fietkau, et al.
Clinical Nuclear Medicine|January 6, 2023
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical CancerSimone Wegen, Katrin Sabine Roth, Jasmin Weindler, et al.
Radiation Oncology (London, England)|April 4, 2024
Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancerSimone Wegen, Karina Claus, Philipp Linde, et al.
Cancers|March 10, 2022
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting SubgroupsMaike Trommer, Anne Adams, Eren Celik, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|June 11, 2021
Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-PatientsJohannes Rosenbrock, Andrés Vásquez-Torres, Horst Mueller, et al.
Radiation Oncology (London, England)|January 3, 2025
Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes-a single centre analysisJulia Katharina Schleifenbaum, Janis Morgenthaler, Shachi Jenny Sharma, et al.
Cancers|September 2, 2020
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score MatchingMaike Trommer, Jaika Kinsky, Anne Adams, et al.
Molecular Imaging and Biology|June 30, 2022
Head-to-Head Comparison of [<sup>68</sup> Ga]Ga-FAPI-46-PET/CT and [<sup>18</sup>F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck CancerSimone Wegen, Lutz van Heek, Philipp Linde, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 13, 2021
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approachPhilipp Linde, Christian Baues, Simone Wegen, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study GroupJohannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 27, 2023
Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)Marcel Büttner, Philip Melton, Rainer Fietkau, et al.
Clinical Nuclear Medicine|January 6, 2023
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical CancerSimone Wegen, Katrin Sabine Roth, Jasmin Weindler, et al.
Radiation Oncology (London, England)|April 4, 2024
Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancerSimone Wegen, Karina Claus, Philipp Linde, et al.
Cancers|March 10, 2022
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting SubgroupsMaike Trommer, Anne Adams, Eren Celik, et al.
Pageof 4